TCR Signaling in T Cell Memory by Mark A. Daniels & Emma Teixeiro
REVIEW
published: 10 December 2015
doi: 10.3389/fimmu.2015.00617
Edited by:
Dietmar Zehn,
Swiss Vaccine Research Institute,
Switzerland
Reviewed by:
Jose Alberola-Ila,
Oklahoma Medical Research
Foundation, USA
Cosima T. Baldari,
University of Siena, Italy
*Correspondence:
Emma Teixeiro
teixeiropernase@missouri.edu
Specialty section:
This article was submitted to T Cell
Biology, a section of the
journal Frontiers in Immunology
Received: 15 September 2015
Accepted: 25 November 2015
Published: 10 December 2015
Citation:
Daniels MA and Teixeiro E (2015) TCR
Signaling in T Cell Memory.
Front. Immunol. 6:617.
doi: 10.3389/fimmu.2015.00617
TCR Signaling in T Cell Memory
Mark A. Daniels and Emma Teixeiro*
Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, USA
T cell memory plays a critical role in our protection against pathogens and tumors.
The antigen and its interaction with the T cell receptor (TCR) is one of the initiating
elements that shape T cell memory together with inflammation and costimulation. Over
the last decade, several transcription factors and signaling pathways that support memory
programing have been identified. However, how TCR signals regulate them is still poorly
understood. Recent studies have shown that the biochemical rules that govern T cell
memory, strikingly, change depending on the TCR signal strength. Furthermore, TCR
signal strength regulates the input of cytokine signaling, including pro-inflammatory
cytokines. These highlight how tailoring antigenic signals can improve immune therapeu-
tics. In this review, we focus on how TCR signaling regulates T cell memory and how the
quantity and quality of TCR–peptide–MHC interactions impact the multiple fates a T cell
can adopt in the memory pool.
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INTRODUCTION
Upon infection or vaccination, T cell receptors (TCRs) recognize antigen bound toMHCmolecules
on the surface of antigen-presenting cells (APCs). Antigen recognition results in the transduction of
TCR signals that enable T cell differentiation. In this process, TCR signals cooperate with cytokine,
costimulatory, chemokine, integrin, and metabolic signals to regulate the acquisition of effector
function and the generation of T cells with very different phenotypes. The degree of synergy between
all the signals mentioned above leads to changes in the levels of a set of transcription factors that
ultimately will determine distinct T cell fates. These includeCD8 short-lived effectors, CD4Thelper:
Th1, Th2, follicular helper T cell (Tfh), GC (germinal center)–Tfh, T cell effector-memory cells
(TEM), T cell central-memory cells (TCM), T cell resident memory cells (TRM), T memory stem cell,
or lymphopenia-induced proliferation (LIP)-memory T cell, etc.
Although a great body of work supports the contribution of the inflammatory and local tissue
environments to T cell differentiation and memory, emerging data suggest that TCR signaling itself
is crucial in this process, especially for T cell memory development. In this review, we discuss these
data and propose the idea that TCR signaling is an essential component that enables the integration
of environmental cues that shape the T cell memory pool.
TCR SIGNAL QUANTITY, QUALITY, AND T CELL FATE
T cell receptor signals are conditioned by different biophysical and biochemical parameters. The
affinity of the TCRαβ heterorodimer for antigenic peptide–MHC molecules (pMHC), the dose
of antigen presented on the surface of APCs, and the duration of the TCR–pMHC interaction,
all determine the strength of TCR signals (1, 2). For a long time, the prevalent idea has been that
memory development requires an intermediate to high overall signal strength. Signals that were too
weak resulted in only a few memory cells that were not fit to survive or respond. By contrast, signals
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that were too strong led to terminally differentiated effectors (3).
This idea holds true on studies focused on T cell clones that
respond to immunodominant epitopes or that bind with high
affinity to cognate antigens. In these studies, these high-affinity T
cells are recruited in large frequencies to the memory pool, in part
due to their greater expansion (4–8). However, in the context of
infection or lymphopenia, even very low affinity antigens support
memory development (9–13). These data suggest that TCR affin-
ity alone is not predictive ofmemory outcome. Indeed, other stud-
ies have found the duration or t1/2 of the pMHC–TCR interaction
(both equilibrium and aggregate half-life) can serve as a better
predictor of memory fate (14, 15). Thus, recent work has shown
that Th1memory fate correlates with long TCR–pMHC t1/2 times
and not with the affinity of the pMHC–TCR interaction or the
ability to expand (16). The relationship between TCR–pMHC I
dwell time and CD8 T cell memory commitment is currently
less clear. It is most likely distinct from CD4 T cells, especially
when considering the different contributions of CD4 and CD8
co-receptors to the stability of the TCR–pMHC interaction and
the narrower range of effector functions for CD8 T cells (17, 18).
The timing and availability of the antigen is also important for
making thememory “choice.” One report has suggested that early-
sustained T cell–APC interactions were absolutely required for the
response of memory cells (but dispensable for the acquisition of
effector function), although a clear effect in memory generation
was not provided (19). By contrast, other reports have shown that
shortening TCR stimulation early or late in the response favors the
generation of memory T cells (20–23). Collectively, these studies
illustrate that a strict quantitative model of TCR signaling cannot
easily explain T cell memory commitment/function and suggest
that the efficiency of an antigen to assemble the TCR signals that
specifically supportmemorymay bemore complex than originally
anticipated.
An alternative to the quantitative model of TCR signaling for
memory is a model that considers the quality of TCR signaling.
In other words, the TCR signals that support the development of
memory may be qualitatively different from the ones required for
other T cell functions (effector function or proliferation). TCR
signal quality could be determined by the strength of the TCR
signal. In this line, Jenkins and colleagues recently showed how
differences in antigen dose/aggregate p-MHCII dwell time can
lead to different CD4 T cell lineage choices. They posit a model
where a low amount of TCR signaling supports Tfh development,
an intermediate amount induces Th1, and large amounts of TCR
signaling enables GC–Tfh differentiation (15, 24). For CD8T cells,
a decreasing potential model has been proposed where the weaker
the signal a T cell receives (over a certain threshold), the higher the
likelihood of the cell to enter in the memory pool (25, 26). This
model does not distinguish between antigenic or inflammatory
signals nor does it take into account the input of signals from the
local tissue environment in determining the phenotypic diversity
of the memory pool. However, it is consistent with the fact that
very weak TCR signals (even in the range of self) are sufficient to
support the memory program (10, 12).
In light of this, it is possible that different T cell outcomes are
achieved at different TCR signaling thresholds. This is not a novel
concept [reviewed in Ref. (27, 28)]. Seminal work by Valittutti
and Lanzavechia originally determined that proliferation required
higher antigen doses than IFNγ secretion or cytotoxicity in human
T cell clones (29). In vivo, it has also been reported that CD8 T
cell proliferation requires longer and higher affinity TCR–pMHC
interactions than what is required for the acquisition of effector
function or memory differentiation (10, 30). Thus, memory fate
may be supported by low-grade TCR signals, which are sufficient
for the acquisition of memory programing but are not strong or
continuous enough to “burn the differentiating T cell to death.”
Consistent with this, T cells favor the expression of memory-
associated transcription factors (23) and preferentially develop
into protective memory T cells in the context of very weak TCR
signals (10, 13, 23). These, together with the fact that memory
precursors can be detected early in the immune response raises
the hypothesis that memory development may be a default path-
way whose TCR signaling threshold is lower than the threshold
required for full expansion or to become short-lived effector (26,
31). T cells survival capacity may be established depending on the
signals that the individual T cell clones continue to experience
during the course of an immune response. That is, T cells exposed
to strong or continued signals become short-lived effectors des-
tined to die (32), whereas T cells receiving slightly weaker signals
are directed into the TEM phenotype. This fosters the intriguing
idea that very early in the response a set of T cells are directed
down the memory path, perhaps, to ensure diversity within the
memory pool (33, 34).
Given that T cells can give rise to a battery of daughter cells of
very different phenotypes and fates; most likely, T cells are not
predetermined to acquire a specific outcome at the naïve level
(35–37). Therefore, qualitatively different biochemical input must
determine each of the fates a T cell can adopt during an immune
response. These qualitatively different biochemical signals may be
defined early in the response or progressively, by a combination
of factors that act at the same time, or in a multistage process.
It is clear that inflammation and tissue-specific signals shape the
phenotypic determination of T effector and memory cells; yet,
experimental evidence still indicates that TCR signals, by them-
selves, are key at inducing memory programs and enabling the T
cells ability to receive the extrinsic signals that help to determine
the diversity of T cell fates (1, 23, 24, 38). In this scenario, TCR
signal quality may be defined independently of the quantity of the
TCR signal and dictated by the singular ability of the antigen to
efficiently assemble a “signalosome” for memory fate that is dis-
tinct from the one required for other T cell functions (discussed in
detail below). This is supported by studies where a point mutation
in one of the constant domains of the TCR allows for expansion
and acquisition of effector function but severely impairs CD8
memory development (39). In this model, the properties of the
TCR–pMHC interactions are intact, affinity and dwell time are
not compromised. Furthermore, there is not an overall reduction
in TCR signaling but rather a defect only in the activation of
TCR-dependent NFκB signaling (39). Thus, TCR signaling to
memory may be defined by the ability of the antigen to induce
the activation of specific signaling pathways key to launch the
memory program. In agreement with this, specific inhibition of
other signaling pathways, such asWnt, mTOR, or NFκB, affects T
cell memory fate decisions very differently (39–41).
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TCR SIGNAL STRENGTH IMPACTS
TCR SIGNAL QUALITY
At the risk of being confusing, it is still important to note that
the composition of the “memory TCR signalosome” may also
change depending on the TCR signal strength. Thus, while the
transcriptional signatures that describe the different “flavors” of
memory cells may be unique, there may be multiple intracellular
signaling options that lead to each fate. Evidence for this has been
revealed in studies where T cells defective in the TCR signalosome
that supports memory in the context of strong TCR signaling,
strikingly were able to regain the ability to differentiate into mem-
ory upon challenge with weak antigens (42). In this case, memory
development correlated with the capacity to activate NFκB sig-
nals and happened even when the activation of other signaling
pathways was impaired (42). This suggests that weak and strong
TCR ligands induce distinct signalosomes rather than different
levels of the same signalosome. Similar conclusions can be reached
from the studies of Tubo and Jenkins where depending on the
TCR signal strength/TCR–pMHC dwell time/antigen dose, dis-
tinct transcriptional profiles could be achieved that supported Tfh,
Th1, and GC–Tfh (15, 24). Whether the transcriptional profiles
that lead to distinct lineages are governed by the early induction
of different TCR signalosomes or controlled by different negative
feedback circuits at the level of the nuclei or both remains to be
determined.
How can different TCR signal strengths imprint distinct bio-
chemical signatures that lead to different T cell fates? A model
for CD4 T helper differentiation has been proposed where the
TCR can support two types of signals (24). One is induced by
default and commits the cells into a lineage. This may be the
case of the signal that supports Bcl-6 expression in Tfh. The other
signal is proportional to the strength of the TCR and implies
the expression of other transcription factors, such as Blimp-1
and T-bet for Th1 (43, 44). The higher the dose of antigen, the
higher the proliferation and the generation of the progeny of the
originally committed Th1 clones. When the TCR signal is too
strong, however, Blimp-1 levels are induced to high levels leading
to apoptosis of Th1 clones (45, 46). On the other hand, the Tfh
clones that originally committed to this lineage, proliferate, induce
higher levels of Bcl-6, and eventually differentiate into GC–Tfh
(24). A similar model could be applied to CD8 T cells, where a
default signal triggered by any engagedTCR, even in the context of
very weak TCR ligands, could induce the expression of memory-
associated factors Bcl-6 and Eomes (but low levels of Blimp-1
and T-bet) (23). In these conditions, weak TCR ligands would
favor the generation of memory T cells with a TCM phenotype
over the generation of effector CD8 cells. If T cells encounter
stronger TCR signals, then the ratio of Bcl-6/Eomes to Blimp-1/T-
bet transcription factors would change. Now, T-bet and Blimp-1
expression would increase, supporting the generation of a large
number of effector cells. When the antigenic signal is too strong,
T-bet and Blimp-1 levels would increase and Bcl-6 and Eomes
levels decrease. This would force the T cells that took the effector
path to continue dividing and die (23, 44). By contrast, T cells
that received an intermediate TCR signal would be skewed into
memory due to a decrease in their T-bet/Blimp-1 levels and/or
a natural recovery of the default signal that keeps high levels of
Eomes and Bcl-6. Therefore, the TCR signal strength a T cell
or their progeny receives may dictate its longevity while specific
phenotypes may be further shaped by a continuum of antigenic
signals, inflammatory cytokines, and local environmental factors
encountered in the course of the response. In agreement with this,
very low affinity TCR ligands induce a signal that supports high
Eomes/T-bet ratios and high levels of Bcl6 that favor memory
development. By contrast, high-affinity TCR ligands at the same
dose support low Eomes/T-bet ratios (23) (Figure 1).
This model reconciles the idea of “one cell-multiple fates” with
the current models of memory ontogeny. However, it is difficult
to test in T cell population studies that cannot track the antigenic
experience of individual cells or distinguish between the different
precursors of each T cell fate. One question, though, remains to
be explained in this model. This is what keeps a T cell in the naïve
stage versus the T cell that develops into memory (TCM) under
very weak TCR signaling. The answer to this question may lie in
the dose of the weak antigen and the cytokinemilieu. For example,
T cells exposed to high doses of weak antigens (in lymphopenic
conditions) and cytokines IL-7 and IL-15 differentiate into cells of
a TCM memory phenotype (13). Alternatively, the ability of a T cell
to remain naïve or differentiate into a TCM phenotypemay depend
on the TCR signals that it received during thymic development. A
hint of how this process may be modulated comes from studies
monitoring CD5hi and CD5lo T cell populations in the periphery.
Expression of CD5, a negative regulator of TCR signals (47, 48),
directly correlates with the strength of the signal generated by the
selecting self-pMHC ligand encountered in the thymus. Despite
this, peripheral CD5hi T cells exhibit a pre-activated profile that
after TCR stimulation leads to stronger responses (49–51). It is
possible that the expression of CD5 conditions whether a naïve
T cell responding to foreign antigen will reach a TCR signal-
ing threshold that will direct it into one T cell fate or another.
Although this has not been formally tested, these studies point to
the idea that a T cell’s TCR signal history can greatly influence its
fate as the environment around it changes (inflammation, tissue
distribution, etc.).
HOW TCR SIGNALING REGULATES
MEMORY DEVELOPMENT
In recent years, the field has focused a great deal of attention
on inflammation and other extrinsic factors and has relegated
TCR/antigenic signals to have a minimal role in the process that
establishes the clonal heterogeneity of the T cell effector or mem-
ory pool. Recent work has brought the TCR back to the forefront
of this debate. We have generated a mouse model where T cells
bearing a point mutation in the transmembrane domain of the
TCRβ chain (βTMDmut) exhibit partial TCR signaling but no
other alterations in peptide–MHC–TCR recognition or cytokine
signaling. Upon Listeria infection, βTMDmut cells were severely
defective in generating memory T cells and memory responses
(39). This was despite the normal ability of the βTMDmut cells
to proliferate and differentiate into effector T cells. Interestingly,
the defect in TCR signaling to memory led to a failure to generate
“IL-7Rhi-memory precursors,” and it was not due to impairment
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FIGURE 1 | Proposed model of how TCR signal strength regulates CD8 T cell memory differentiation. The interactions of TCR–pMHC on a naïve CD8 T cell
triggers TCR signals of varying strength. A default TCR signal leads to low levels of T-bet and Blimp-1 and higher levels of Eomes and Bcl-6 skew the naïve T cell into
a central-memory phenotype. This weak TCR signal can be achieved by strong or very weak ligands. If the TCR signal is intermediate, then T cells integrate IL-2 and
other pro-inflammatory signals, which allow for similar up-regulation of all transcription factors depicted. This ensures the acquisition of effector function early in the
response. Once antigen and inflammation decrease due to clearance of the pathogen, effector T cells decrease their levels of Blimp-1 and T-bet and regain higher
ratios of Bcl-6/Blimp-1 and Eomes/T-bet allowing them to become memory T cells. For the cases where the naïve T cell receives very strong TCR signals, the
Bcl-6/Blimp-1 and Eomes/T-bet ratios are too low and ultimately lead to apoptosis.
in receiving inflammatory or homeostatic input (42). These results
challenged the idea that the TCR is a mere spark plug in the T
cell memory differentiation process and showed that the TCR
signaling requirements are not the same for all T cell outcomes.
This idea is further supported by a study from Smith-Garvin and
colleagues, which also explored the role of TCR signaling inCD8T
cell differentiation by targeting a downstream intermediate of the
TCR signalosome, SLP-76. Employing a knock-in mouse model
that expressmutant SLP-76, they showed compelling evidence that
the TCR signaling requirements for CD8 effector and memory
development are different (52). Furthermore, another study using
a conditional SLP-76 model also suggested that tonic TCR signals
are required beyond the peak of the response tomaintainmemory
CD4 T cell homeostasis and to regulate CD8 memory generation
(53, 54). Noteworthy, these and other recent studies (52, 55, 56)
have also helped to consolidate the idea that not all the fates that
a T cell can adopt are interrelated; that the potential of a T cell to
choose the path toward a specific fate and not another can already
be determined early in the response; and finally, that not only
extrinsic factors but also cell intrinsic TCR-dependent signals or
programs may be important to establish the heterogeneity of the
effector and memory pools.
How TCR signaling to memory is defined biochemically at
the level of signal transduction, transcriptional regulation, and
metabolism is beginning to come to light. TCR stimulation
results in the activation of several signaling pathways [such as
Ca2+/NFAT; CBM/PKCθ/NFκB, Vav/Rac/POSH/JNK, RasGRP,
or Sos-Ras/RafK/ERK, PI3K, mTOR, Wnt (57, 58)] that, in some
cases, are shared with other surface receptors. This is the case
for CD28, chemokine receptors, or some TNF receptors that can
each utilize membrane proximal intermediates of TCR signaling,
such as PI3K or PKCθ (59–61). To date, attempts to demonstrate
the role of these specific pathways in T cell differentiation have
implied the use of gain/loss of function approaches based on the
overexpression of dead or constitutive active forms or a complete
deletion of intermediates of the signaling cascades under study.
It is important to keep in mind that these approaches can lead
to an imbalance in the signaling cross-talk that naturally occurs
in a T cell under physiological conditions. Thus, while the con-
clusions of these studies are extremely informative regarding the
role of the specific signaling intermediates in T cell differentiation,
they cannot be exclusively ascribed to the TCR. We generated
a TCR transgenic model where T cells bearing TCRs mutant in
the βTMD are specifically deficient in memory differentiation.
This model allowed us to connect TCR with signal transduction
to memory. We found that the memory defect was not a conse-
quence of an overall change in the activation of the signaling path-
ways supported by the TCR signalosome. By contrast, memory
differentiation-defective T cells were singularly impaired in the
induction of the NFκB signaling pathway (39). Furthermore, once
βTMDmut T cells regained the ability to induce NFκB signals,
their capacity to differentiate into memory T cells was restored
(23). Together, these strongly suggest that TCR-dependent NFκB
signaling is crucial for the generation of memory T cells.
T cell receptor-dependent NFκB signaling involves the
activation of PKCθ, which enables the assembly of the
Carma1/Bcl10/Malt1 (CBM) complex. The CBM complex,
in turn, recruits the IKK complex (IKKα, IKKβ, and NEMO)
to the membrane to be activated in a TRAF2/6 and TAK1-
dependent manner (62). The importance of NFκB signaling
in memory development is manifested in EDA-ID (anhidrotic
ectodermal dysplasia with immunodeficiency) patients, which
carry a gain-of-function mutation of IκBα (an NFκB inhibitor)
that leads to impaired NFκB activation and a lack of memory
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T cells (63). Previous reports utilizing murine models targeting
IKKβ or IκBα in T cells also indicated that NFκB signaling
pathway was important for generation of memory-phenotype
T cells (64, 65). More recently, other studies have also involved
members of the non-canonical NFκB cascade in the development
of memory T cells (66, 67). However, none of these studies
revealed the biochemical mechanism behind the role of NFκB
in T cell memory, and only the study by Parker and colleagues
addressed its role in the context of infection (67).
An important aspect to consider regarding the NFκB pathway
is its ability to regulate different T cell outcomes depending on the
level of activation, the kinetics of activation, and the developmen-
tal stage or type of T cell. For example, deletion of IKKβ results
in a defect in generating memory-phenotype T cells. By contrast,
chronic activation of NFκB signaling in T cells responding to
Listeria infection results in increased apoptosis, which results in
defective memory (68). This may be related to the fact that IKKβ,
while essential for the induction of NFκB, is also involved in
the negative regulation of the cascade and can inhibit early TCR
signaling (68, 69). In addition, NFκB signals exhibit different
waves of induction after stimuli have gone. How this contributes
to T cell fate decisions is also not known (70–73). Finally, it
is worthy to note that members of the TCR-dependent NFκB
signaling cascade differ in their individual contributions to the
final T cell outcome in CD8 versus CD4 T cells. Thus, constitutive
activation of IKKβ leads to enhanced CD4 negative selection
but has no effect on CD8 T cells (74). T-cell-specific deletion
of NEMO or TAK1 prevents the development of both CD4 and
CD8 peripheral T cells (65, 75). However, PKCθ, Carma-1, or
Bcl10 deletion do not appear to contribute to selection in the
thymus, but are remarkably involved in CD4 regulatory T cell
development. They also regulate Th17 and Th2, but not Th1
differentiation and contribute to the generation of CD4 memory-
phenotype T cells (60, 76–78). Murine and human T cells lacking
Carma-1 or Bcl-10 are inefficient at developing a CD8 and CD4
memory-phenotype T cells (79, 80), although the role of these
intermediates in T cell memory development has not been fully
characterized in the context of infection. An important role for
TRAF-6 in CD8 T cell memory but not effector development has
also been described (55). TRAF-6 contributes to IKKγ activation
and NFκB induction and we have noticed that CD4 TRAF-6
deficient T cells exhibit defects in IκBα phosphorylation and
degradation, together with the described enhanced phosphoryla-
tion of PI3K/Akt (81). Interestingly, the role of TRAF-6 in CD8
T cell memory development is mediated by the regulation of
fatty acid metabolism, although whether this occurs in an NFκB-
independent fashion is unclear (55). Collectively, these studies
show that NFκB-dependent T cell outcomes are determined by
multiple and complex mechanisms. Thus, future research will
need to consider all of the aspects described above to thoroughly
understand how this signaling pathway regulates T cell effector
responses and memory development.
Ras/ERK, PI3K/Akt, and mTOR signaling pathways are also
induced upon TCR stimulation and have recently been linked
to the development of memory T cells. Ras is a GTPase that is
activated by Sos or RasGRP, both GEFs are actively regulated
by the TCR signalosome (57). The isoform N-Ras is crucial for
ERK-independent regulation of CD8 T cell memory development
via regulation of Eomes (82, 83). On the other hand, mTOR
signaling was originally described as a key regulator of pro-
inflammatory IL-12 and homeostatic IL-7 cytokine signals in CD8
memory programing, particularly through its control of the tran-
scription factors T-bet and Eomes (41, 84). Additionally, mTOR
is a central regulator of cell metabolism, growth, survival, and
proliferation. mTORC1 (the rapamycin target) is activated upon
TCR stimulation (85) via Carma-1 and Malt-1 (86); however, its
continuous activation depends on the integration of TCR signals
with other cytokine signals, such as IL-12 (41). mTORC2 plays a
more important role in cell survival and cytoskeletal regulation
(87) and can activate Akt to control mTORC1 (88). The relative
contribution of mTORC1 and mTORC2 in T cell memory devel-
opment has remained elusive, although a recent study by Powell
and colleagues supports a differential role for these complexes in
CD8 T cell effector/memory responses and memory maintenance
(89). How the two mTOR complexes interpret differences in TCR
signal strength in the context of other environmental cues to direct
themetabolic changes that accompany the transition tomemory is
unclear. Remarkably, agonistic TCR stimulation results in strong
activation of ERK and PI3K/Akt, both involved in the activation
of high levels of mTORC1. This supports the idea that strong
TCR signals are optimal for effector differentiation and may be
detrimental for programing memory longevity via transcription
factors such as IRF-4, Blimp-1, or T-bet that can suppress Eomes
expression (90, 91). Little is known of how T cells switch from
mTORC1- tomTORC2-dependent metabolism to transition from
effector to memory. Similarly, it is unclear whether TCR signals
regulatemTORC2 and their ability to control themetabolic repro-
graming that T cells need to differentiate intomemory (89).When
considering the TCR signal strength constraints of each of the
Th subsets (1) with the fact that Th1 and Th17 differentiation
is mTORC1 dependent while Th2 is mTORC2 dependent, it is
tempting to speculate that mTORC2 might play a major role on
memory T cells that have been selected on the basis of low TCR
signals, such as TCM (89) or TRM, which are highly dependent
on Foxo1!KLF2! S1P1 [a target of mTORC2 (92, 93)]. On
the contrary, TEM cells that are selected in higher TCR signaling
conditions might be more dependent on mTORC1.
Another signaling pathway important for memory generation
is Wnt signaling. Inhibition of GSK3β mimics Wnt signaling and
skews differentiating T cells into a memory stem cell phenotype
that provides superior proliferative and antitumor capabilities (40,
94). Wnt signaling requirement for the generation of memory
does not appear to require β-catenin (95) but rather targets the
transcription factor TCF-1 to regulate Eomes expression (96).
TCR signaling can activate Wnt signaling via PI3K/Akt and PKC
(40, 97). However, constitutive active Akt signaling diminishes
TCF-1, Lef1, andMyc leading to a loss ofmemoryT cells (98). This
suggests that, similar to the NFκB pathway, PI3K/Akt signaling
appear to have opposing effects on the survival or development of
T cell memory depending on the level of activation. This, then,
posits the idea that for at least some signaling pathways, there
may be specific thresholds that a T cell needs to meet in order to
progress into one T cell fate or another.Whether there is a set time
in T cell differentiation where the level of the signaling pathway in
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question fully commits a T cell into a particular fate is not known.
It is also possible that at any time intrinsic and extrinsic factors
could both contribute to the total level of the specific signaling
pathway and determine whether the T cell would progress toward
a specific phenotype or another.
Finally, another complex and important issue is signaling cross-
talk. Signaling pathways can often synergize and/or regulate each
other. This applies to TCR signaling pathways and metabolic
signaling pathways. For example, it is well known that NFκB sig-
naling and GSK3β can modulate mTOR signaling (99, 100), and
vice versa,mTOR signaling can alsomodifyNFκB signaling (101).
Therefore, special attention should be made to the interactions
between signaling pathways and how they change depending on
the environmental cues, especially when considering therapeuti-
cal approaches that aim to activate or suppress a specific signaling
pathway.
HOW TCR SIGNALING SHAPES THE
PHENOTYPIC DIVERSITY OF MEMORY
The memory pool is not homogenous and it is now well accepted
that different T cell memory subsets, such as TSCM, TCM, TEM,
and TRM coexist. Each contributes in unique ways to provide
full protection against re-infection. Recent studies are shedding
light into how TCR signaling may be regulating each one of these
memory fates. TCR-dependent NFκB signals are more important
for CD8 TCM cells (23). Wnt signaling, however, appear to be
crucial for CD8 TSCM (40) while sustained mTOR signaling is
required for the accumulation of TRM in the mucosa (102).
The requirement of TCR signals for TRM is more controversial.
Certain features of TRM such as αEβ7 expression may be upreg-
ulated in mucosal tissue independent of the presence of antigen.
Indeed, cognate antigenic signals are not required for the develop-
ment of TRM in the intestine, in the female reproductive tract, and
in the skin (103, 104). On the other hand, TRM development in
lung, CNS, and PNS requires antigen (105). Remarkably, none of
these studies has assessed whether tonic self-peptide TCR signal-
ing is required for TRM development or maintenance. Similarly, a
fine distinctionneeds to bemade regardingwhether there is a TCR
signal that favors the generation of TRM upon priming or whether
this occurs within the tissue (106).
The relationship between TCR signaling transduction andCD4
T cell memory diversity is also not completely clear. Mounting
evidence supports that TCR signal strength plays a role in the
generation of TEM versus TCM CD4 cells similar to CD8 T cells,
with strong TCR signals guiding the commitment to one of the
TEM lineages and weaker stimulation favoring the generation of
TCM (107). Recently, TEM (Th1-like) and TCM cell fates have
been identified by virtue of their unique expression of T-bet or
Bcl-6 (108). It is possible that strong TCR signals driving Th1
differentiation lead to high levels of Blimp-1, which consequently,
would repress the expression of Bcl-6, and commit Th1 effectors to
the TEM fate (109). Weak TCR signals, in turn, could lead to low
levels of Blimp-1 and T-bet and higher expression of Bcl6, sup-
porting TCM differentiation. Alternatively, Bcl-6 could be already
expressed as a default and only T cells able to express high levels
of IL-2R would repress Bcl-6 while keeping high levels of Blimp-1
and T-bet would direct them into the Th1–TEM phenotype (24,
110). Nevertheless, further research is needed to address howTCR
signaling is connected to Bcl6, Blimp-1, or T-bet.
MAINTAINING T CELL MEMORY
CD4 and CD8 memory T cells exhibit distinct requirements
for self-peptide–MHC signals to maintain their memory status.
Different models have demonstrated that CD8 memory T cell
longevity does not require tonic TCR signals (111, 112). On the
contrary, self-p-MHC/TCR signals are pivotal for the survival of
CD4 memory T cells although a comprehensive description of
which type of TCR-dependent signaling cascades are supporting
this process is still missing (113, 114). Assessing this would imply
the use of conditional systems that allow for specific ablation of the
particular signaling pathway at memory. In this line, two studies
have addressed the role of early TCR signaling intermediates Lck
and SLP-76 at memory using conditional deletion of the genes
encoding these proteins. These studies surprisingly show that
while Lck is not required for CD8 or CD4 T cell memory (54,
115, 116), SLP-76 is crucial only for CD4 T cell memory home-
ostatic turnover (53). In studies exploring the role of mTORC1
and NFκB signaling to maintain CD8 memory fate fidelity, we
have found that NFκB signals are crucial to promote the longevity
and the response of CD8 memory T cells. Interestingly, NFκB at
memory does not appear to be maintained by known extrinsic
factors but rather is programed early in the response by TCR
signals (Knudson and Teixeiro, manuscript in review), unfolding
another unexpected role for TCR-dependent regulation in the
maintenance of T cell memory.
THE SYNERGY OF TCR AND
INFLAMMATORY SIGNALS FOR
T CELL MEMORY
Cytokines in general have been proven to be crucial “transform-
ers” of T cell differentiation covering from full acquisition of
effector functions to the generation or maintenance of memory T
cells (117, 118). Pro-inflammatory cytokines, in particular, have
been suggested to control the sensitivity of the T cell response
upon re-exposure to the same antigen (119). The converse axiom
whether TCR signals regulate the input or sensitivity of inflamma-
tory signals is also true. The strength of TCR signals can regulate
the input of inflammation by directly controlling the expression
of pro-inflammatory cytokine receptors and TGFβR (23) on CD8
T cells. The same phenomenon has been reported for CD4 T
cells (38) and together, strongly indicates that TCR signals govern
sensitivity to inflammation and perhaps to other environmental
signals (120) in a hierarchical multistage process.
Antigen and inflammation can, then, regulate each other’s input
at different points in the life of a T cell, but the thresholds of this
regulation for each of the signals are unknown. Inflammation does
not appear to compensate for weak T cell responses of TCR signal
strengths that are well above the threshold for thymic selection
(121). However, there may be other scenarios where these signals
may cooperate or temper each other (122). This could happen
at the most proximal membrane level or by regulating similar
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signaling pathways in the presence or in the absence of cognate
antigen. Although this has not been fully explored, a few studies
support this hypothesis. For example, it has been described that
the chemokine receptor CXCR4, critical for TCM cell renewal and
homing to the bone marrow (123, 124), physically associates with
the TCR to signal in the absence of foreign antigen (125). This
area of research certainly awaits further investigation and it can
greatly aid in the identification of molecular checkpoints that can
be exploited for therapeutics.
CONCLUDING REMARKS
Memory T cells are an essential part of our immune system
that protect against pathogens and tumors. How memory T cells
are generated and maintained are still unsolved questions. The
memory T cell pool that remains upon infection or vaccination
is heterogeneous, containing memory cells phenotypically diverse
and with different specialized functions as well. This hetero-
geneity is the result of how the differentiating T cell integrates
antigen, inflammation, costimulation, chemokine, homeostatic,
and metabolic signals. At the beginning of the immune response,
antigen receptor (TCR signals), pro-inflammatory cytokines (IL-
12R/TypeIIFN), and costimulatory signals trigger the differen-
tiation of T cells to acquire effector functions and to become
memory cells. A fabulous effort in the field has provided ample
insight into how inflammation impacts T cell memory differen-
tiation and the diversity of the memory pool. However, recent
data have brought up to stage the role of antigen and TCR
signals in determining T cell memory. Experimental evidence
supports that TCR signals are not a default but rather an essen-
tial component that enables the integration of all environmen-
tal cues that shape the T cell effector and memory pool. How-
ever, the mechanisms by which the TCR operates to control
the final T cell’s outcome are far from clear. As the different
layers of regulation of TCR signaling unfold, more questions
arise regarding how differences in TCR signal strength regulate
the fidelity of the transcriptional program that controls memory
development andmemory quality orwhy specific TCR-dependent
signaling pathways are more important than others at regulat-
ing T cell memory. Likewise, how TCR signaling cooperates in
time and space with inflammatory and local tissue environmen-
tal signals and what their relative contribution is to memory
differentiation is an exciting area that awaits further investiga-
tion and is expected to aid greatly in a better design of current
immunotherapies.
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